Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: 2321GCCC: CRD3874-SI in Patients With Relapsed/Refractory AML [Phase 1]
A Phase 1 trial of CRD3874-SI for relapsed or refractory acute myeloid leukemia has been suspended.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies [Phase 1]
Phase 1 clinical trial update describing the completion of a study evaluating HLA-mismatched microtransplantation without immunosuppressive …
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Study Evaluating the Efficacy and Safety of the Addition of Ivosidenib to Oral Azacitidine (Onureg®) in Patients Over 55 With Acute Myeloid Leukemia (AML) and IDH1 Mutation, in Complete Remission After Intensive Chemotherapy. [Phase 2]
A Phase 2 trial is evaluating whether adding ivosidenib to oral azacitidine (Onureg) improves outcomes in patients over 55 with IDH1-mutated…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome [Phase 2]
Phase 2 study of venetoclax in combination with decitabine for relapsed/refractory acute myeloid leukemia or relapsed high-risk myelodysplas…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders [NA]
This update reports the completed status of a trial assessing bone marrow and kidney transplant for patients with chronic kidney disease and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia [Phase 1]
A Phase 1 trial is evaluating CLAG-M or FLAG-Ida chemotherapy with reduced-intensity conditioning donor stem cell transplant for relapsed or…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia [Phase 2]
A randomized Phase 2 trial (BLAST MRD AML-1) evaluates adding pembrolizumab to intensive chemotherapy as frontline therapy for acute myeloid…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies [Phase 2]
Phase 2 clinical trial update evaluating TCRαβ-depleted progenitor cell graft with added memory T-cell donor lymphocyte infusion and selecti…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia [Phase 1]
This document provides an update on a Phase 1 trial of venetoclax in combination with decitabine for acute myeloid leukemia, with the study …
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Pevonedistat and Belinostat in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1]
Phase 1 study of pevonedistat in combination with belinostat for relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes …
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia [NA]
This clinical trial update from Massachusetts General Hospital describes a collaborative palliative and oncology care model for patients wit…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy [Phase 1]
This clinical trial update describes a Phase 1 study of edetate calcium disodium or succimer in patients with acute myeloid leukemia or myel…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia [Phase 1]
Phase 1 trial evaluating the safety of a multi-agent regimen (CDX-1401, Poly ICLC, Decitabine, and Nivolumab) in patients with myelodysplast…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia [Phase 3]
A Phase 3 clinical trial sponsored by the Children's Oncology Group is evaluating whether xylitol dental wipes can reduce bloodstream infect…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Uproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid Leukemia [Phase 1]
Phase 1 trial combining uproleselan, azacitidine, and venetoclax in newly diagnosed acute myeloid leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: A Phase 1 Study of BMF-500 in Adults With Acute Leukemia [Phase 1]
A Phase 1 trial evaluating BMF-500 in adults with acute leukemia is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Liposomal Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin for the Treatment of Relapsed Refractory Pediatric Patients With Acute Myeloid Leukemia [Phase 1]
A Phase 1 trial evaluating the safety and feasibility of a liposomal cytarabine, daunorubicin, and gemtuzumab ozogamicin combination in rela…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating liposome-encapsulated daunorubicin-cytarabine (CPX-351) in combination with gemtuzumab ozogamicin for relapsed or r…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias [Phase 1]
A Phase 1 clinical trial update reports that SNDX-5613 is being studied in combination with intensive chemotherapy for acute myeloid leukemi…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute Myeloid Leukemia [Phase 1]
Phase 1/1b trial of olutasidenib and ziftomenib for NPM1 and IDH1 co-mutated acute myeloid leukemia is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome [Phase 2]
This Phase 2 clinical trial investigates the combination of azacitidine and enasidenib for IDH2-mutant myelodysplastic syndrome and is curre…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease [Phase 1]
Phase 1 trial evaluating interferon-γ-primed mesenchymal stromal cells as prophylaxis for acute graft-versus-host disease in patients with a…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Characteristics and Outcomes of Acute Myeloid Leukemia (AML) Patients Treated With Oral-Azacitidine Maintenance Therapy in France
A completed French clinical trial reports characteristics and outcomes of acute myeloid leukemia patients treated with maintenance therapy u…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission [Phase 2]
Phase 2 trial evaluating oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in Japanese patients …
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia [Phase 1]
This Phase 1 clinical trial update reports dose escalation and expansion of Ziftomenib in combination with Quizartinib for Acute Myeloid Leu…